相关实验视频
Updated: Jul 8, 2026

08:38
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
药物诱导的口吃:一个案例研究
Thales De Nardo1, Elizabeth A Minton2
1Department of Communication Sciences & Disorders, Western Carolina University, United States.
Journal of fluency disorders
|June 6, 2025
概括
本案例研究突出了一个罕见的例子,在使用 gabapentin 和 lexapro 后持续获得的口吃. 专注于认知和情感因素的治疗,而不仅仅是流利,改善了患者的生活质量.
科学领域:
- 神经科学是一个神经科学.
- 语音语言病理学 语言病理学
背景情况:
- 获得的口吃可能是某些药物的副作用,包括 gabapentin.
- 以前的药物诱导口吃病例通常在停止药物治疗后得到解决.
研究的目的:
- 在使用 gabapentin和lexapro后报告持续获得的口吃病例.
- 为了评估语音治疗的有效性,目标因素超出了获得性口吃的流利性.
主要方法:
- 一个26岁的女性新发严重口吃的案例研究.
- 进行了神经学和运动语言检查.
- 语音治疗专注于口吃的次要行为,认知和情感方面.
主要成果:
- 患者在开始服用 gabapentin 和 lexapro 后四天出现了严重的口吃.
- 尽管停止了药物治疗,但口吃持续了多年.
- 标准的流度塑造策略是无效的.
- 治疗改善了认知,情感,生活质量和口吃严重程度的指标.
结论:
- 加巴丁和莱克萨普罗可以导致持续的获得性口吃.
- 针对认知和情感组成部分的综合性语言治疗对获得的口吃是有效的.
- 这一案例强调了在治疗中考虑非流动性因素的重要性.
更多相关视频
相关概念视频
Taste Buds and Receptors
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
Drug Delivery: Enteral Route
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs in...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.

